TrialRheumatology (Oxford, England)2021

Intravenous immunoglobulins as first-line treatment in idiopathic inflammatory myopathies: a pilot study.

Johan Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.